Karuna Therapeutics, Inc. announced that Steve Paul, M.D., resigned as Chief Scientific Officer and President of Research and Development of the Company on January 16, 2024, effective immediately. Dr. Paul will continue to serve as a member of the Company?s Board of Directors and, from and after such date, will serve as a member of the Company?s scientific advisory board. On January 16, 2024, the Company announced that Andrew Miller, Ph.D., the Company?s Founder and current Chief Operating Officer, has been appointed as President of Research and Development of the Company, with such appointment effective immediately.

Dr. Miller, age 42, has served as the Company's Chief Operating Officer since August 2018, and served as a member of the Board from April 2012 to March 2019. Dr. Miller was a founder of the Company, and prior to serving as Chief Operating Officer, he was the Company?s President and Chief Executive Officer from July 2016 to August 2018. From August 2008 to July 2016, Dr. Miller held several positions at PureTech Health plc, last serving as a Vice President, Venture Partner, and in such capacity served as Chief Operating Officer of Tal Medical and acting Chief Operating Officer of Entrega, Inc. He is currently a member of the board of directors of Entrega, Inc. Dr. Miller received a B.S. in Chemical Engineering from the University of Illinois with high honors and completed his Ph.D. in Chemical Engineering at the Massachusetts Institute of Technology.